Paclitaxel in the treatment of carcinosarcoma of the uterus: a gynecologic oncology group study

Gynecologic Oncology
J P CurtinK DeGeest

Abstract

The goal of this study was to estimate the clinical activity of paclitaxel in patients with persistent or recurrent carcinosarcoma of the uterus who have failed other treatments. The Gynecologic Oncology Group (GOG) conducted a phase II study of paclitaxel 170 mg/m(2) (135 mg/m(2) in those with prior irradiation) intravenously every 3 weeks in patients with histologic confirmation of carcinoma and measurable disease who had failed appropriate local therapy. A total of 53 patients were entered into the study between September 1994 and January 1997; 44 patients were evaluable for response. The median age of the patients treated was 65 years (range: 38-79). Twenty-six patients had heterologous mixed mesodermal tumors (MMTs) and 18 patients had homologous tumors. A median of three courses were administered (range: 1-18). Fifteen patients had previous radiation therapy and 33 patients had failed prior chemotherapy. Eight patients (18.2%) had a response to paclitaxel: four patients had a complete response and four had a partial response. Neutropenia was the most common toxic effect. Paclitaxel had moderate activity in patients with carcinosarcoma of the uterus. The GOG is currently studying the combination of paclitaxel and ifosfamid...Continue Reading

Citations

Sep 26, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·P Reichardt
May 10, 2006·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·M MurakamiM Ide
Jun 29, 2006·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·K KokawaN Umesaki
Jun 29, 2006·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·L WongJ J Low
Apr 28, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Matthew A PowellFrederick R Ueland
Oct 24, 2007·European Journal of Nuclear Medicine and Molecular Imaging·Kung-Chu HoHuei-Jean Huang
Mar 23, 2011·Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology·M OkazawaY Tomita
Jul 15, 2011·Best Practice & Research. Clinical Obstetrics & Gynaecology·Martee L Hensley
Jun 24, 2008·Clinical Oncology : a Journal of the Royal College of Radiologists·N S Reed
Aug 21, 2007·Critical Reviews in Oncology/hematology·Angiolo GadducciAndrea Riccardo Genazzani
Jul 13, 2007·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Sarah ParkKeunchil Park
Sep 17, 2015·Current Treatment Options in Oncology·Joseph Menczer
Aug 18, 2012·Asia-Pacific Journal of Clinical Oncology·Yoshihito YokoyamaHideki Mizunuma
Mar 26, 2005·Gynecologic Oncology·Joseph MenczerAmi Fishman
May 3, 2005·Gynecologic Oncology·Sindu KanjeekalShailendra Verma
Mar 26, 2015·Gynecologic Oncology·Leigh A CantrellLinda R Duska
Jun 19, 2013·Gynecologic Oncology·Gregory Sutton
Dec 4, 2014·Critical Reviews in Oncology/hematology·Grazia ArtioliFranco Garbin
Jul 10, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Gini F Fleming
Feb 10, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Howard D HomesleyUNKNOWN Gynecologic Oncology Group
Feb 1, 2011·Journal of Gynecologic Oncology·Dong Hoon SuhSoon-Beom Kang
Mar 2, 2013·The Cochrane Database of Systematic Reviews·Khadra GalaalAlberto D Lopes
Aug 1, 2014·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Domenica LorussoFrancesco Raspagliesi
Dec 7, 2007·The American Journal of Surgical Pathology·Sarah E FergusonRobert A Soslow
Oct 13, 2009·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Mauro SignorelliNicoletta Colombo
Feb 19, 2008·Expert Review of Anticancer Therapy·Maurie Markman
Dec 25, 2012·Expert Review of Anticancer Therapy·Diana P EnglishAlessandro D Santin
Mar 31, 2018·South Asian Journal of Cancer·Anne George CherianAbraham Peedicayil

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Carcinosarcoma

Carcinosarcoma is a malignant neoplasm that contains elements of carcinoma and sarcoma so extensively intermixed as to indicate neoplasia of epithelial and mesenchymal tissue. Discover the latest research on carcinosarcoma here.